Related Experiment Videos
Microtubule-associated proteins tau and amyloid P component in Alzheimer's disease
T Duong1, T Doucette, N A Zidenberg
1Indiana University School of Medicine, Terre Haute Center for Medical Education, Terre Haute 47809.
Abstract:
The localization of the intracerebral microtubule-associated proteins tau (MAP-tau) has been compared to that of amyloid P component (AP), an extracerebral protein, by single- and double-antigen immunohistochemistry in neurofibrillary tangles of Alzheimer's brains. The results show that, individually, MAP-tau and AP may be observed in all stages of neurofibrillary tangle (NFT) formation. However, NFT labeled by MAP-tau and those labeled by AP largely do not overlap in their distribution. Furthermore, within the few NFT double-labeled by MAP-tau and AP, there was an inverse relationship between the immunoreactivity to MAP-tau and to AP. It is suggested that MAP-tau and AP are incorporated at different times into NFT and that this difference in the timing of NFT expression of these 2 proteins may be useful in the study of progressive NFT formation.
Insights
Microtubule-associated protein tau (MAP-tau) and amyloid P component (AP) are found in Alzheimer's neurofibrillary tangles (NFTs). Their distinct distributions suggest different incorporation times during NFT development, aiding progressive tangle studies.
Area of Science:
- Neuroscience
- Neuropathology
- Alzheimer's Disease Research
Background:
- Alzheimer's disease is characterized by neurofibrillary tangles (NFTs).
- Key components of NFTs include microtubule-associated protein tau (MAP-tau) and amyloid P component (AP).
- Understanding the temporal and spatial relationship of these proteins is crucial for elucidating NFT formation.
Purpose of the Study:
- To compare the localization of MAP-tau and AP within NFTs in Alzheimer's brains.
- To investigate the temporal incorporation of MAP-tau and AP during NFT development.
- To assess the utility of these proteins as markers for progressive NFT formation.
Main Methods:
- Single- and double-antigen immunohistochemistry techniques were employed.
- Analysis was performed on neurofibrillary tangles from Alzheimer's disease brains.
- Immunoreactivity patterns of MAP-tau and AP were meticulously documented.
Main Results:
- Both MAP-tau and AP were individually present across all stages of NFT formation.
- NFTs labeled for MAP-tau and those labeled for AP showed largely non-overlapping distributions.
- A few double-labeled NFTs exhibited an inverse relationship between MAP-tau and AP immunoreactivity.
Conclusions:
- MAP-tau and AP are likely incorporated into NFTs at different times during their development.
- The distinct temporal incorporation of these proteins offers a valuable tool for studying progressive NFT formation.
- This differential timing provides insights into the dynamic processes underlying Alzheimer's neuropathology.